Endothelin receptor antagonists

Details Endothelin receptor antagonists Endothelin receptor antagonists

1996-08-15

1998-10-13

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514367, 514375, 514379, 514381, 514382, 514387, 514394, 514414, 514416, 514417, 514418, 514419, 548159, 548169, 548171, 548178, 548252, 548217, 548221, 548241, 548259, 5483044, 5483064, 5483097, 5483615, 548454, 548469, 548472, 548475, 548480, 548482, 548483, 548486, 548488, 548491, 548503, C07D20948, C07D20946, C07D20904, A61K 3134, A61K 31405, A61K 3141, A61K 3142, A61K 31425

Patent

active

058212566

ABSTRACT:
Novel compounds of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3 and X have the meaning indicated in claim 1, and their salts exhibit endothelin receptor-antagonistic properties.

REFERENCES:
patent: 5292740 (1994-03-01), Burri et al.
Williams et al., "Pharmacology of L-754,142 . . . " J. of Pharm. and Exp. Ther., vol. 275, No. 3, pp. 1518-1526.

Affiliated with

Also associated with

Rating

Endothelin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endothelin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-313510